SRI International   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Menlo Park CA United States (1946)

Organization Overview

First Clinical Trial
2004
NCT00166543
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

SRI International